2015至2017年早发型新生儿脓毒症:大肠埃希菌增多及新型预防策略需求
EOS发生率随胎龄降低而显著升高,22-28周婴儿最高(18.47/1000)。最常见病原体为大肠埃希菌(36.6%)和B组链球菌(GBS,30.2%),大肠埃希菌感染主要见于早产儿,GBS感染主要见于足月儿。死亡38例,均发生于胎龄<37周的早产儿(29.0%),足月儿无死亡。
要点
- EOS总发生率1.08/1000活产,22-28周早产儿高达18.47/1000。
- 大肠埃希菌(36.6%)和GBS(30.2%)是最常见病原体,大肠埃希菌主要感染早产儿。
- 死亡38例均发生于胎龄<37周早产儿(29.0%),足月儿无死亡。
核心结论
- EOS发生率和相关死亡主要集中于早产儿,当前GBS预防策略存在局限性。
- 极低出生体重儿(401-1500g)大肠埃希菌感染率较2006-2009年监测显著上升(8.68 vs 5.07/1000活产,P=.008)。
- 氨苄西林和庆大霉素在多数病例中仍有效,但需持续监测EOS病原体药敏。
研究设计与样本
- EOS定义为出生72小时内血或脑脊液培养分离出致病菌且抗生素治疗至少5天或直至死亡。
主要发现
- 共235例EOS(男127例,54.0%),总发生率1.08/1000活产(95%CI 0.95-1.23)。
- 胎龄22-28周婴儿EOS发生率最高(18.47/1000,95%CI 14.57-23.38),性别、种族和民族间无显著差异。
- 大肠埃希菌86例(36.6%),其中早产儿68/131(51.9%);GBS 71例(30.2%),其中足月儿54/104(51.9%),45例GBS病例中24例(53.3%)母亲GBS筛查阴性。
- 162名母亲(68.9%)接受产时抗生素(早产儿110/131[84.0%],足月儿52/104[50.0%]),最常见指征为疑似绒毛膜羊膜炎。
- 220/235(93.6%)EOS新生儿在出生72小时内出现疾病征象;死亡38/131(29.0%)感染早产儿,足月儿无死亡。
关键数值与推荐
- EOS诊断标准:出生72小时内血或脑脊液培养分离出致病菌且抗生素治疗至少5天或直至死亡。
- 大肠埃希菌分离株中仅18/81(22.2%)对氨苄西林敏感;6/77(7.8%)对氨苄西林和庆大霉素均耐药。
- 极低出生体重儿大肠埃希菌感染率8.68/1000活产(95%CI 6.50-11.60) vs 2006-2009年5.07/1000活产(95%CI 3.93-6.53),P=.008。
临床怎么用
- 对早产儿尤其极低出生体重儿应高度警惕EOS,经验性抗生素常包含氨苄西林和庆大霉素。
- 母亲GBS筛查阴性不能完全排除新生儿GBS感染,需结合临床征象判断。
- 持续监测EOS病原体分布及药敏,以指导经验性抗生素选择和预防策略调整。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Early-onset sepsis (EOS) remains a potentially fatal newborn condition. Ongoing surveillance is critical to optimize prevention and treatment strategies. OBJECTIVE: To describe the current incidence, microbiology, morbidity, and mortality of EOS among a cohort of term and preterm infants. DESIGN, SETTING, AND PARTICIPANTS: This prospective surveillance study included a cohort of infants born at a gestational age (GA) of at least 22 weeks and birth weight of greater than 400 g from 18 centers of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network from April 1, 2015, to March 31, 2017. Data were analyzed from June 14, 2019, to January 28, 2020. MAIN OUTCOMES AND MEASURES: Early-onset sepsis defined by isolation of pathogenic species from blood or cerebrospinal fluid culture within 72 hours of birth and antibiotic treatment for at least 5 days or until death. RESULTS: A total of 235 EOS cases (127 male [54.0%]) were identified among 217 480 newborns (1.08 [95% CI, 0.95-1.23] cases per 1000 live births). Incidence varied significantly by GA and was highest among infants with a GA of 22 to 28 weeks (18.47 [95% CI, 14.57-23.38] cases per 1000). No significant differences in EOS incidence were observed by sex, race, or ethnicity. The most frequent pathogens were Escherichia coli (86 [36.6%]) and group B streptococcus (GBS; 71 [30.2%]). E coli disease primarily occurred among preterm infants (68 of 131 [51.9%]); GBS disease primarily occurred among term infants (54 of 104 [51.9%]), with 24 of 45 GBS cases (53.3%) seen in infants born to mothers with negative GBS screening test results. Intrapartum antibiotics were administered to 162 mothers (68.9%; 110 of 131 [84.0%] preterm and 52 of 104 [50.0%] term), most commonly for suspected chorioamnionitis. Neonatal empirical antibiotic treatment most frequently included ampicillin and gentamicin. All GBS isolates were tested, but only 18 of 81 (22.2%) E coli isolates tested were susceptible to ampicillin; 6 of 77 E coli isolates (7.8%) were resistant to both ampicillin and gentamicin. Nearly all newborns with EOS (220 of 235 [93.6%]) displayed signs of illness within 72 hours of birth. Death occurred in 38 of 131 infected infants with GA of less than 37 weeks (29.0%); no term infants died. Compared with earlier surveillance (2006-2009), the rate of E coli infection increased among very low-birth-weight (401-1500 g) infants (8.68 [95% CI, 6.50-11.60] vs 5.07 [95% CI, 3.93-6.53] per 1000 live births; P = .008). CONCLUSIONS AND RELEVANCE: In this study, EOS incidence and associated mortality disproportionately occurred in preterm infants. Contemporary cases have demonstrated the limitations of current GBS prevention strategies. The increase in E coli infections among very low-birth-weight infants warrants continued study. Ampicillin and gentamicin remained effective antibiotics in most cases, but ongoing surveillance should monitor antibiotic susceptibilities of EOS pathogens.
引用
- Stoll BJ, Puopolo KM, Hansen NI, et al. Early-Onset Neonatal Sepsis 2015 to 2017, the Rise of Escherichia coli, and the Need for Novel Prevention Strategies. JAMA Pediatr. 2020. PMID: 32364598. doi:10.1001/jamapediatrics.2020.0593
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。